Corporate insider profile
Deborah J Andrews Insider Trades
Deborah J Andrews has reported 1 open-market purchase on SEC Form 4 and is a net buyer of $20,000 across 1 company. The most recent open-market transaction was reported on Nov 16, 2026. Source: SEC Form 4 filings.
Latest reported as Director of Lineage Cell Therapeutics, Inc. (LCTX).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $20,000
- Latest transaction
- Nov 16, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Deborah J Andrews insider trading FAQ
- Is Deborah J Andrews buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Deborah J Andrews is a net buyer of $20,000, with 1 open-market purchase reported. The latest transaction was reported on Nov 16, 2026.
- Which companies does Deborah J Andrews report insider trades for?
- Deborah J Andrews has reported open-market trades in Lineage Cell Therapeutics, Inc. (LCTX). The latest SEC-reported relationship is Director of Lineage Cell Therapeutics, Inc. (LCTX).
- Where does Deborah J Andrews's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1325697, and refreshes this page daily.
